ARTICLE | Clinical News
Rasival aliskiren/valsartan regulatory update
September 20, 2010 7:00 AM UTC
The European Medicines Agency (EMA) said Novartis withdrew an MAA for Rasival aliskiren/valsartan to treat hypertension. According to the agency, the pharma said it would not be able to address reques...